Did any news come out of this?!
There may actually be double the amount of people in the USA livig with Heptatis B than what the CDC estimates
http://onlinelibrary.wiley.com/doi/10.1002/hep.24804/abstract
Here in the US they lower the statistics of HBV infections. If you were not born here you are told that you got it where you were born. Which for many asians is true even though the genotype clearly points to north america.
Also because of past health insurance discrimination towards us many people did not report their infection or even tested for it. There is no mandatory testing of young adults for these viruses on university campuses as an example.
Those thar are in their 20s yeah all were vaccinated for the majority. It is people in their 30 and above that were not.
But the numbers are huge worldwide. And it is abig shame on these drug companies going very slowly with the process of releasing better treatments.
Replicor has what works now proven. And yet they dont go public with this.
So at least Arrowhead is trying to rapidly develop their drug and let the public know that they are on a path to do so first.
Well I am glad he went on television and speaks about it. This is what Replicor should have done as they do have a finished product.
I can't wait to hear more, especially with good news. However, I have a bad feeling that this drug will not be released in the major areas. 350-400 million is a LOT of people. Surely it will be controlled to certain areas (I pray it is not so we ALL get it!) I'm amazed to learn that only 2 million in the USA are affected with this. That is a very small minority of my country's population, and unfortunately I fall into it :( Also, let's hope the drug will not be costing a fortune like the Hep C drug.